The Patient Reported Outcomes, Burdens and Experiences (PROBE) Project: Development and evaluation of a questionnaire assessing patient reported outcomes in people with haemophilia

被引:39
|
作者
Skinner M.W. [1 ]
Chai-Adisaksopha C. [2 ,10 ]
Curtis R. [3 ]
Frick N. [4 ]
Nichol M. [5 ]
Noone D. [6 ]
O'Mahony B. [6 ,7 ]
Page D. [8 ]
Stonebraker J.S. [9 ]
Iorio A. [2 ,10 ]
机构
[1] Institute for Policy Advancement Ltd, 1155 23rd Street NW #3A, Washington, 20037, DC
[2] McMaster University, Department of Medicine, Hamilton
[3] Factor VIII Computing, Berkeley
[4] National Hemophilia Foundation, New York
[5] University of Southern California, Sol Price School of Public Policy, Los Angeles
[6] Irish Haemophilia Society, Dublin
[7] Trinity College Dublin, Dublin
[8] Canadian Hemophilia Society, Montreal
[9] North Carolina State University, Poole College of Management, Raleigh
[10] McMaster University, Department of Health Research Methods, Evidence, and Impact, Hamilton
关键词
Haemophilia; Patient-centered research; Patient-reported outcomes; Quality of life;
D O I
10.1186/s40814-018-0253-0
中图分类号
学科分类号
摘要
Background: The interest of health care agencies, private payers and policy makers for patient-reported outcomes (PRO) is continuously increasing. There is a substantial need to improve capacity to collect and interpret relevant PRO data to support implementation of patient-centered research and optimal care in haemophilia. The Patient Reported Outcomes, Burdens and Experiences (PROBE) Project aims to develop a patient-led research network, to develop a standardized questionnaire to gather patient-reported outcomes and to perform a feasibility study of implementing the PROBE questionnaire. Methods: A pilot questionnaire was developed using focus group methodology. Content and face validity were assessed by a pool of persons living with haemophilia (PWH) and content experts through interactive workshops. The PROBE questionnaire was translated with the forward-backward approach. PROBE recruited national haemophilia patient non-governmental organizations (NGOs) to administer the questionnaire to people with and without haemophilia. PROBE measured the time to complete the questionnaire and gathered feedback on its content and clarity; staff time and cost required to implement the questionnaire were also collected. Results: The PROBE questionnaire is comprised of four major sections (demographic data, general health problems, haemophilia-related health problems and health-related quality of life using EQ-5D-5L and EQ-VAS). Seventeen NGOs participated in the pilot study of the PROBE Project, recruiting 656 participants. Of these, 71% completed the questionnaire within 15 min, and all participants completed within 30 min. The median total staff and volunteer time required for the NGOs to carry out the study within their country was 9 h (range 2 to 40 h). NGO costs ranged from $22.00 to $543.00 USD per country, with printing and postage being the most commonly reported expenditures. Conclusions: The PROBE questionnaire assesses patient-important reported outcomes in PWH and control participants, with a demonstrated short completion time. PROBE proved the feasibility to engage diverse patient communities in the structured generation of real-world outcome research at all stages. © 2018 The Author(s).
引用
收藏
相关论文
共 50 条
  • [21] Integration of Patient Reported Outcomes in Drug Development in Genitourinary Cancers
    Risa L. Wong
    Alicia K. Morgans
    Current Oncology Reports, 2020, 22
  • [22] Patient-reported outcomes and patient voices
    Asci, Gulay
    Ok, Ercan
    SEMINARS IN DIALYSIS, 2022, 35 (05) : 457 - 458
  • [23] Patient-reported outcomes in drug safety evaluation
    Basch, E.
    ANNALS OF ONCOLOGY, 2009, 20 (12) : 1905 - 1906
  • [24] Assessing Patient-Reported Outcomes for Patients with Neurogenic Bladder
    Choe C.
    Lucioni A.
    Current Bladder Dysfunction Reports, 2013, 8 (4) : 277 - 281
  • [25] Longitudinal evaluation of the oral mucositis weekly questionnaire-head and neck cancer, a patient-reported outcomes questionnaire
    Epstein, Joel B.
    Beaumont, Jennifer L.
    Gwede, Clement K.
    Murphy, Barbara
    Garden, Adam S.
    Meredith, Ruby
    Le, Quynh-Thu
    Brizel, David
    Isitt, John
    Cella, David
    CANCER, 2007, 109 (09) : 1914 - 1922
  • [26] Patient-reported outcomes in drug development for hematology
    Acquadro, Catherine
    Regnault, Antoine
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2015, : 496 - 500
  • [27] Patient-Reported Outcomes: Time to Integrate Into Outcomes Reporting?
    Medbery, Rachel L.
    Fernandez, Felix G.
    Khullar, Onkar, V
    SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2019, 31 (04) : 856 - 860
  • [28] Patient Reported Outcomes and Measures in Children with Rhabdomyosarcoma
    Van Gorp, Marloes
    Grootenhuis, Martha A. A.
    Darlington, Anne-Sophie
    Wakeling, Sara
    Jenney, Meriel
    Merks, Johannes H. M.
    Hjalgrim, Lisa Lyngsie
    Adams, Madeleine
    CANCERS, 2023, 15 (02)
  • [29] The History of Patient-Reported Outcomes in Rheumatology
    Callahan, Leigh F.
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2016, 42 (02) : 205 - +
  • [30] Patient-Reported Outcomes and Surgical Quality
    Hyland, Colby J.
    Pusic, Andrea L.
    Liu, Jason B. B.
    CLINICS IN COLON AND RECTAL SURGERY, 2023, 36 (04) : 259 - 264